冠状动脉旁路移植术患者围术期贫血防治的研究进展*

doi:10.3969/j.issn.1671-2587.2023.04.025

临床输血与检验 ›› 2023, Vol. 25 ›› Issue (4): 555-558.DOI: 10.3969/j.issn.1671-2587.2023.04.025

冠状动脉旁路移植术患者围术期贫血防治的研究进展^*

高原¹, 高旭蓉¹, 高洁², 纪宏文^{1, 2}

中国医学科学院阜外医院; ¹输血科; ²麻醉科,北京 100037

收稿日期:2023-05-26 出版日期:2023-08-20 发布日期:2023-09-18
通讯作者: 纪宏文,主任医师,博士生导师,主要从事心血管手术麻醉与患者血液管理研究,（E-mail）jihongwen@fuwai.com。
作者简介:高原,主要从事临床输血工作,（E-mail）gaoyuan031120@126.com。
基金资助:
*本课题受中国医学科学院医学与健康科技创新工程基金（No.2021-I2M-1-060）资助

Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

GAO Yuan, GAO Xurong, GAO Jie, et al

Department of Blood Transfusion,Fuwai Hospital Chinese Academy of Medical Sciences,Beijing 100037

Received:2023-05-26 Online:2023-08-20 Published:2023-09-18

摘要/Abstract

摘要： 贫血会导致冠状动脉旁路移植术患者围术期输血率与输血量增加,住院时间延长,同时也是术后并发症率与死亡率的独立危险因素。患者血液管理是以患者为中心、基于循证和系统的方法,通过诊治围术期贫血和保护患者自体血液,以改善患者结局。本文对冠状动脉旁路移植术患者围术期贫血防治研究进展进行综述,希望对改进冠状动脉旁路移植术贫血患者治疗方案、改善患者临床结局有所裨益。

关键词: 贫血, 冠状动脉旁路移植术, 血液管理

Abstract: Anemia leads to increased perioperative blood transfusion rate and blood transfusion volume, prolonged hospital stay in coronary artery bypass grafting patients, and is also an independent risk factor for postoperative complications and mortality.Patient blood management is a patient-centered, systematic, evidence-based approach to improve patient outcomes through the diagnosis and treatment of perioperative anemia and the protection of autologous blood.This paper reviews the research progress in the prevention and treatment of perioperative anemia in patients with coronary artery bypass grafting, which hopely improves the treatment plan and clinical outcome of patients with anemia after coronary artery bypass grafting.

Key words: Anemia, Coronary artery bypass grafting, Patient blood management

中图分类号:

R457

高原, 高旭蓉, 高洁, 纪宏文. 冠状动脉旁路移植术患者围术期贫血防治的研究进展^*[J]. 临床输血与检验, 2023, 25(4): 555-558.

GAO Yuan, GAO Xurong, GAO Jie, et al. Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(4): 555-558.

参考文献

[1] LAPAR D J,HAWKINS R B,MCMURRY T L,et al.Preoperative anemia versus blood transfusion:which is the culprit for worse outcomes in cardiac surgery?[J].J Thorac Cardiovasc Surg,2018,156(1):66-74.e2.
[2] 北京医学会输血医学分会,北京医师协会输血专业专家委员会.患者血液管理——术前贫血诊疗专家共识[J].中华医学杂志,2018,98(30):2386-2392.
[3] SHANDER A,HARDY J F,OZAWA S,et al.A global definition of patient blood management[J].Anesth Analg,2022,135(3):476-488.
[4] KIM C J,CONNELL H,MCGEORGE A D,et al.Prevalen ce of preoperative anaemia in patients having first-time cardiac surgery and its impact on clinical outcome.A retrospective observational study[J].Perfusion,2015,30(4):277-283.
[5] CARRASCAL Y,MAROTO L,REY J,et al.Impact of preoperative anemia on cardiac surgery in octogenarians[J].Interact CardioVasc Thorac Surg,2010,10(2):249-255.
[6] MICELI A,ROMEO F,GLAUBER M,et al.Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery[J].J Cardiothorac Surg,2014,9:137.
[7] MAZLAN A,AYOB Y,HUSSEIN A,et al.Factors influencing transfusion requirement in patients undergoing first-time,elective coronary artery bypass graft surgery[J].Asian J Transfus Sci,2017,11(2):95.
[8] HUNG M,BESSER M,SHARPLES L D,et al.The prevalence and association with transfusion,intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients[J].Anaesthesia,2011,66(9):812-818.
[9] CAMASCHELLA C.Iron deficiency:new insights into diagnosis and treatment[J].Hematology,2015,2015(1):8-13.
[10] 王文婷,刘晋萍.促红细胞生成素在心血管手术中应用的研究进展[J].临床麻醉学杂志,2023,39(1):89-92.
[11] CHO B C,SERINI J,ZORRILLA-VACA A,et al.Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients:results from a systematic review and meta-analysis[J].Anesth Analg,2019,128(5):981-992.
[12] TANAKA A,OTA T,URIEL N,et al.Cardiovascular surgery in Jehovah’s Witness patients:the role of preoperative optimization[J].J Thorac Cardiovasc Surg,2015,150(4):976-983.e1-3.
[13] D'AMBRA M N.Commentary:we need to know more about erythropoietin[J].JTCVS Tech,2020,4:158-159.
[14] CHO B C,SERINI J,ZORRILLA-VACA A,et al.Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients:results from a systematic review and meta-analysis[J].Anesth Analg,2019,128(5):981-992.
[15] DUCE L,COOTER M,MCCARTNEY S,et al.Outcomes in patients undergoing cardiac surgery who decline transfusion and received erythropoietin compared to patients who did not:a matched cohort study[J].Anesth \& Analg,2017,127:490-495.
[16] 张宗久,胡豫,Axel Hofmann,等.促进实施患者血液管理的专家倡议[J].中国卫生质量管理,2022,29(9):81-86.
[17] 中华人民共和国国家卫生健康委员会.围手术期患者血液管理指南(WS/T 796-2022)[EB/OL].(2022-01-21)[2022-05-07].http:// www.nhc.gov.cn/wjw/s9493/202202 /5e3bc1a664094da692bcb3e2e85efd34.shtml.
[18] 程珍珍,姚媛媛,严敏.成人心脏手术患者围术期贫血管理研究进展[J].中国输血杂志,2022,35(5):582-586.
[19] HIRATA Y.Cardiopulmonary bypass for pediatric cardiac surgery[J].Gen Thorac Cardiovasc Surg,2018,66(2):65-70.
[20] GROCOTT H P,FARAONI D.Avoidance of hyperoxemia during cardiopulmonary bypass:why does pathophysiology not always translate into clinical outcome?[J].Anesthesiology,2018,128(2):419.
[21] MAZZONE A L,BAKER R A,MCNICHOLAS K,et al.Circulating and urinary miR-210 and miR-16 increase during cardiac surgery using cardiopulmonary bypass-A pilot study[J].J Extra Corpor Technol,2018,50(1):19-29.
[22] 胡强,袁媛,于坤,等.氨甲环酸对于不同体外循环预充液凝血功能的影响[J].中国分子心脏病学杂志,2021,21(4):4091-4095.
[23] BOETTCHER W,REDLIN M,DEHMEL F,et al.Asanguineous priming of miniaturized paediatric cardiopulmonary bypass circuits for congenital heart surgery:independent predictors associated with transfusion requirements and effects on postoperative morbidity[J].Eur J Cardiothorac Surg,2018,53(5):1075-1081.
[24] 李倩,吕红,刘岳,等.心血管手术围术期抗纤溶治疗的有效性及安全性[J].中国临床药理学与治疗学,2021,26(7):830-835.
[25] COUTURE P,LEBON J S,LALIBERTÉ É,et al.Low-dose versus high-dose tranexamic acid reduces the risk of nonischemic seizures after cardiac surgery with cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,2017,31(5):1611-1617.
[26] PABINGER I,FRIES D,SCHÖCHL H,et al.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis[J].Wien Klin Wochenschr,2017,129(9/10):303-316.
[27] RUNYON M S.Topical tranexamic acid for epistaxis in patients on antiplatelet drugs:a new use for an old drug[J].Acad Emerg Med,2018,25(3):360-361.
[28] SHI J,ZHOU C H,PAN W,et al.Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery:the OPTIMAL randomized clinical trial[J].JAMA,2022,328(4):336-347.
[29] 田丽娟,纪宏文,康文英,等.快速血栓弹力图对冠状动脉旁路移植术后严重出血危险因素的评估研究[J].北京医学,2020,42(10):992-996.
[30] 刘刚,李勇男,刁晓林,等.新型改良低预充体外循环系统的临床应用[J].中国体外循环杂志,2020,18(5):295-300.
[31] 高思哲,周纯,闫姝洁,等.新型改良低预充体外循环系统在成人心脏外科手术中有效性的随机对照试验方案[J].中国体外循环杂志,2022,20(5):272-275.
[32] 刘燕,王中,张达雄,等.血液回收技术在心外科手术中的应用[J].中国输血杂志,2003,16(1):14-15.
[33] 谢鹏禄,董书强,张兆喻,等.自体血液回收在心血管手术中及术后的应用[J].临床军医杂志,2014,42(5):544-545.
[34] SHOU B L,ARAVIND P,ONG C S,et al.Early reexploration for bleeding is associated with improved outcome in cardiac surgery[J].Ann Thorac Surg,2023,115(1):232-239.
[35] 申聪玉,钟泰迪.体外循环下心脏手术术后再次开胸止血原因分析及处理[J].浙江医学,2018,40(10):1113-1114.
[36] 中华人民共和国国家卫生健康委员会.儿科输血指南(WS/T 795-2022)[EB/OL].(2022-01-21)[2022-06-01].http://www.nhc.gov.cn/fzs/s7852d/202202/1484f47dcf824ee8bae3ad7b6809e603/files/d1cfad6849c945b591556494b3de7d2d.
[37] CARSON J L,CARLESS P A,HEBERT P C.Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion[J].Cochrane Database Syst Rev,2012,4(4):CD002042.
[38] ROUBINIAN N H,ESCOBAR G J,LIU V,et al.Trends in red blood cell transfusion and 30-day mortality among hospitalized patients[J].Transfusion,2014,54(10 Pt 2):2678-2686.
[39] MAZER C D,WHITLOCK R P,FERGUSSON D A,et al.Restrictive or liberal red-cell transfusion for cardiac surgery[J].N Engl J Med,2017,377(22):2133-2144.
[40] MAZER C D,WHITLOCK R P,FERGUSSON D A,et al.Six-month outcomes after restrictive or liberal transfusion for cardiac surgery[J].N Engl J Med,2018,379(13):1224-1233.
[41] 高洁,纪宏文.成人心血管外科围术期患者血液管理研究进展[J].北京医学,2022,44(8):746-749.

冠状动脉旁路移植术患者围术期贫血防治的研究进展^*

Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	耿凌云, 李景琦. 儿科患者血液管理的挑战与思考[J]. 临床输血与检验, 2023, 25(4): 439-443.
[2]	郭天虹, 王雨涵, Claudia SC, 黄远帅. 基于研究证据的输血医学新进展[J]. 临床输血与检验, 2023, 25(4): 572-576.
[3]	中国输血协会免疫血液学专业委员会. 输血依赖型地中海贫血（TDT）患者临床输血中国专家共识[J]. 临床输血与检验, 2023, 25(2): 163-169.
[4]	黄蓉, 张宁洁, 郝珂, 郭天虹, 黄雪原, 谷兰, 傅云峰, 黄远帅, 王勇军, 陈秉宇, 周岚, 桂嵘. 从《AABB技术手册》（18版-20版）看国际输血技术新走向^*[J]. 临床输血与检验, 2023, 25(2): 170-179.
[5]	夏悦昕, 刘志远, 宋文倩, 邵林楠, 梁晓华, 周世航. 先天性纯红细胞再生障碍性贫血氧化应激相关差异表达基因的生物信息学分析[J]. 临床输血与检验, 2023, 25(1): 82-87.
[6]	陈蕊, 吕孟兴, 尹加忠, 沈经纬, 熊荣, 白云艳, 周文彪, 王旭, 杨琦, 屈柯暄. 云南省地中海贫血儿童输血安全策略的研究^*[J]. 临床输血与检验, 2022, 24(6): 710-715.
[7]	胡恒雅, 周小玉. 术前贫血对先天性心脏病患儿围术期输血及预后的影响分析[J]. 临床输血与检验, 2022, 24(6): 721-724.
[8]	魏超, 胥俊越, 席朝运, 赵锦阳, 关迺喆, 汪德清. 回顾性分析老年骨科患者用血特点及影响因素^*[J]. 临床输血与检验, 2022, 24(6): 736-742.
[9]	中国输血协会临床输血学专业委员会. 非心脏外科围手术期患者血液管理专家共识（2022版）[J]. 临床输血与检验, 2022, 24(5): 545-553.
[10]	陈学军, 徐军, 尹明伟, 周超, 沈月芳. 英格兰临床和实验室输血五年计划：输血2024的要点及启示[J]. 临床输血与检验, 2022, 24(5): 560-564.
[11]	宋倩, 马怡然. 自身抗体阳性致配血不相合红细胞输注疗效分析[J]. 临床输血与检验, 2022, 24(5): 588-590.
[12]	潘雪, 宋英伟, 林洁, 张晓娟, 张婷, 刘丽, 汪德清, 于洋. 骨科手术患者术前贫血对围手术期输血与临床结局的影响[J]. 临床输血与检验, 2022, 24(4): 409-415.
[13]	周琳, 慈璇, 邵小宝, 王华, 杨圆, 高凤威, 朱培元. 结直肠恶性肿瘤患者围手术期输血和术后感染并发症的相关性研究^*[J]. 临床输血与检验, 2022, 24(4): 416-421.
[14]	王莉, 王立新, 秦莉. 应用D-L抗体检测辅助诊断阵发性冷性血红蛋白尿症1例[J]. 临床输血与检验, 2022, 24(4): 515-517.
[15]	李津杞, 臧艳, 李津婴, 查占山, 钱宝华. 输血治疗儿童遗传性难治性溶血性贫血的回顾性分析[J]. 临床输血与检验, 2022, 24(3): 325-327.